Dtp-Hepb-Hib (Pentavalent) Vaccine Suppliers & Bulk Manufacturers
Available Forms: Injectable suspension (IM injection)
Available Strengths: 0.5 mL dose
Reference Brands: Pediarix(US)
Category:
Vaccines
The DTP-HepB-Hib pentavalent vaccine stimulates immunity against diphtheria, tetanus, pertussis, hepatitis B, and Haemophilus influenzae type b by inducing protective antibody production. It prevents serious childhood diseases, reduces morbidity and mortality, and streamlines immunization schedules—offering comprehensive protection with a single dose.
DTP-HepB-Hib (Pentavalent) Vaccine is available in Injectable suspension (IM injection)
and strengths such as 0.5 mL dose.
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, DTP-HepB-Hib (Pentavalent) Vaccine is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
DTP-HepB-Hib (Pentavalent) Vaccine can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Product Description:
DTP-HepB-Hib pentavalent vaccines are approved in the US and EU, supported by dossiers demonstrating safety, efficacy, and manufacturing quality in compliance with GMP standards. In the US, FDA approval involves rigorous clinical evaluations, while in the EU, CE marking certifies conformity with in vitro diagnostic regulations. These vaccines undergo validation, stability testing, and extensive audits, with documentation including safety profiles, clinical trial data, and manufacturing details. For detailed licensing procedures, approved dossiers, and the latest regulatory updates, visit Pharmatradz. Ensuring compliance guarantees timely access to safe, effective vaccines vital for global immunization efforts, reducing childhood disease burden worldwide.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing